---
author: "Hollow House Institute"
last_updated: "2025-12-02"
status: "DRAFT"
---

# Investor Dataset Summary

## Executive Overview

The Hollow House Institute creates and maintains high-quality, ethically-sourced datasets for trauma-informed AI research. This document provides an overview of our dataset portfolio, business model, and value proposition for investors.

## Mission and Vision

**Mission**: Advancing ethical AI development through trauma-informed, rigorously anonymized datasets that protect participant privacy while enabling breakthrough research.

**Vision**: To become the premier source for ethical mental health and relational AI datasets, setting industry standards for privacy, transparency, and responsible AI development.

## Market Opportunity

### Market Size
- **AI in Healthcare**: $X billion market, growing at Y% CAGR
- **Mental Health Tech**: $X billion market, growing at Y% CAGR  
- **Ethical AI Training Data**: Emerging market with high growth potential

### Market Gap
Current gaps we address:
1. **Lack of trauma-informed datasets** for mental health AI development
2. **Privacy concerns** limiting healthcare data access
3. **Insufficient diversity** in existing mental health datasets
4. **Unclear ethical standards** in AI training data
5. **Poor documentation** of dataset limitations and biases

### Our Solution
We provide:
- Rigorously anonymized, ethically-sourced datasets
- Comprehensive documentation and ethical guidelines
- Trauma-informed research frameworks
- Tiered access model supporting sustainability
- Active research community and support

## Dataset Portfolio

### Current Offerings

#### TIMH-001: Trauma-Informed Mental Health Dataset
**Status**: Beta Release  
**Size**: ~10,000 anonymized records  
**Revenue Tier**: All tiers  
**Use Cases**: Therapeutic AI, treatment effectiveness research, trauma response analysis  

**Market Differentiation**:
- First major trauma-informed mental health dataset
- Rigorous anonymization (k=5, l-diversity applied)
- Comprehensive documentation
- Growing adoption in academic research

#### RAI-001: Relational AI Interaction Dataset
**Status**: Planning  
**Projected Release**: [Q2 2026]  
**Projected Size**: [TBD]  
**Target Market**: Ethical AI companies, academic researchers

**Unique Value**:
- Novel focus on human-AI relational dynamics
- Co-regulation framework application
- Critical for next-generation AI assistants

#### CSC-001: Crisis Support Conversation Dataset
**Status**: In Development  
**Projected Release**: [Q3 2026]  
**Projected Size**: [TBD]  
**Target Market**: Crisis intervention AI, mental health platforms

**Strategic Importance**:
- High-value use case (crisis intervention)
- Premium pricing justified by enhanced anonymization
- Partnership opportunities with crisis services

### Pipeline (3-5 Year Horizon)

1. **Longitudinal Treatment Outcomes** - Track progress over time
2. **Diverse Cultural Perspectives** - Global mental health approaches
3. **AI Safety Evaluation Benchmarks** - Testing harmful use cases
4. **Synthetic Data Validation** - Quality assessment datasets

## Business Model

### Revenue Streams

**Primary Revenue: Dataset Licensing**
- **Tier 1 (Academic)**: Free access → Brand building, research citations
- **Tier 2 (Enhanced)**: $500/year → Sustainable researcher support
- **Tier 3 (Enterprise)**: $5,000+/year → Primary revenue driver

**Secondary Revenue**:
- Custom dataset development (partnerships)
- Consulting on ethical AI development
- Training and certification programs
- API access (premium tier)

**Future Revenue**:
- Dataset marketplace platform
- Privacy-preserving analytics tools
- Ethical AI assessment services

### Pricing Strategy

**Value-Based Pricing**:
- Free tier drives adoption and citations
- Paid tiers priced based on use case value
- Enterprise pricing reflects commercial value created
- Custom pricing for strategic partnerships

**Market Positioning**:
- Premium positioning vs. commodity data
- Emphasis on quality, ethics, and compliance
- Differentiation through documentation and support

### Unit Economics

**Per-Customer Economics** (Illustrative):

**Enterprise Customer**:
- Annual contract value: $5,000-$50,000
- Customer acquisition cost: $[TBD]
- Lifetime value (5 years): $[TBD]
- Gross margin: [High - low incremental cost per customer]

**Cost Structure**:
- **Fixed Costs**: Infrastructure, staff, overhead
- **Variable Costs**: Support, data processing, compliance
- **Marginal Cost per User**: Very low (digital product)

## Market Position and Competition

### Competitive Landscape

**Direct Competitors**:
- Academic research datasets (free, limited scope)
- Commercial data brokers (privacy concerns, unethical practices)
- Healthcare data aggregators (HIPAA-compliant but limited AI focus)

**Indirect Competitors**:
- Synthetic data companies
- Open-source dataset initiatives
- In-house data collection by large companies

### Competitive Advantages

1. **Ethical Standards**: Industry-leading privacy and ethics framework
2. **Documentation Quality**: Comprehensive dataset and model cards
3. **Domain Expertise**: Deep understanding of trauma-informed care
4. **Community**: Growing researcher network and ecosystem
5. **Trust**: Transparent practices build institutional credibility
6. **Compliance**: GDPR, CCPA, HIPAA expertise reduces customer risk

### Barriers to Entry

- **Data Access**: Difficult to establish healthcare data partnerships
- **Expertise Required**: Combines mental health, AI, privacy, and legal expertise
- **Reputation**: Takes years to build researcher trust
- **Network Effects**: Dataset users create community value
- **Regulatory Compliance**: Complex, costly, requires specialized knowledge

## Growth Strategy

### Phase 1: Foundation (Current - Year 2)
**Goals**:
- Establish 3-5 core datasets
- Build researcher community (100+ active users)
- Generate academic citations and validation
- Achieve financial sustainability

**Tactics**:
- Free tier driving adoption
- Conference presence and publications
- Strategic academic partnerships
- Community building and support

### Phase 2: Scale (Year 2-4)
**Goals**:
- Expand to 10+ datasets
- 1,000+ researchers and 50+ enterprise customers
- Diversify revenue streams
- Establish international presence

**Tactics**:
- Geographic expansion (EU, Asia)
- Vertical expansion (new domains beyond mental health)
- Platform development (self-service access)
- Partnership programs

### Phase 3: Platform (Year 4-7)
**Goals**:
- Marketplace for third-party ethical datasets
- Industry-standard certification program
- 10,000+ users across all tiers
- Exit opportunities or sustained profitability

**Tactics**:
- Open platform for vetted dataset providers
- Certification and training programs
- Consulting and services expansion
- Strategic M&A or partnership

## Financial Projections

### Revenue Forecast (Illustrative)

**Year 1**: $[X] - Primarily grants and initial customers  
**Year 2**: $[X] - Growing enterprise base  
**Year 3**: $[X] - Scaled operations  
**Year 5**: $[X] - Market leadership position

*Note: Detailed financial model available in separate document*

### Key Metrics

**User Metrics**:
- Total users (by tier)
- Monthly active users
- User retention rate
- Average revenue per user (ARPU)

**Dataset Metrics**:
- Dataset utilization rate
- Citation count (academic impact)
- Customer satisfaction scores
- Dataset quality metrics

**Business Metrics**:
- Customer acquisition cost (CAC)
- Lifetime value (LTV)
- Gross margin
- Net revenue retention

## Team and Expertise

### Core Team
[To be filled with actual team information]

**Expertise Coverage**:
- Clinical psychology and trauma-informed care
- AI/ML and data science
- Privacy and security engineering
- Healthcare compliance and legal
- Business development and operations

### Advisory Board
[To be filled with advisors]

**Advisor Areas**:
- AI ethics and safety
- Healthcare data privacy
- Mental health research
- Business and scaling

### Hiring Plan
[Growth in team size aligned with funding and scaling]

## Funding Use and Milestones

### Capital Requirements

**Seed/Series A**: $[X]M

**Allocation**:
- Dataset development (40%): Collection, curation, anonymization
- Platform development (25%): Infrastructure, access systems
- Team expansion (25%): Key hires in engineering, research, business
- Operations (10%): Legal, compliance, overhead

### Key Milestones

**12 Months**:
- 3 production datasets
- 100 active researchers
- 10 enterprise customers
- $[X] ARR

**24 Months**:
- 5 production datasets
- 500 active researchers
- 30 enterprise customers
- $[X] ARR

**36 Months**:
- 10 production datasets
- 1,000+ researchers
- 75+ enterprise customers
- $[X] ARR
- Break-even or profitability

## Risk Factors

### Regulatory Risk
**Risk**: Changes in privacy regulations could increase compliance costs  
**Mitigation**: Proactive compliance, conservative standards, legal expertise

### Market Risk
**Risk**: Slower adoption of AI in mental health than projected  
**Mitigation**: Diversify into adjacent domains, focus on broader AI safety market

### Technology Risk
**Risk**: Advances in re-identification could compromise anonymization  
**Mitigation**: Continuous monitoring, conservative approach, ability to recall datasets

### Competition Risk
**Risk**: Large tech companies develop competing datasets  
**Mitigation**: Focus on ethics/quality differentiation, community building, partnerships

### Key Person Risk
**Risk**: Loss of key team members with specialized expertise  
**Mitigation**: Documentation, team building, advisory network

## Social Impact

Beyond financial returns, we create positive social impact:

**Research Advancement**:
- Accelerating ethical AI development
- Improving mental health treatment
- Advancing trauma-informed care

**Privacy Protection**:
- Setting industry standards for anonymization
- Protecting vulnerable populations
- Building public trust in health data use

**Responsible AI**:
- Preventing harmful AI applications
- Promoting transparency and accountability
- Supporting AI safety research

## Exit Strategy

### Potential Exit Paths

1. **Strategic Acquisition**:
   - Healthcare data companies
   - Large tech companies with AI ethics focus
   - Electronic health record (EHR) vendors
   - Mental health platforms

2. **Financial Acquisition**:
   - Private equity interested in data businesses
   - Consolidation in ethical AI space

3. **IPO**:
   - Long-term path if significant scale achieved
   - Requires substantial growth and profitability

4. **Sustainable Independence**:
   - Bootstrap to profitability
   - Operate as mission-driven, profitable business
   - Strategic for maintaining values and mission

### Timeline to Exit
Target: 5-7 years, depending on growth trajectory and market conditions

## Investment Highlights

**Why Invest in Hollow House Institute?**

1. **Large, Growing Market**: AI healthcare and mental health tech expansion
2. **Differentiated Offering**: Unique ethical positioning in crowded market
3. **Strong Unit Economics**: High-margin digital product with low customer costs
4. **Defensible Position**: Expertise, trust, and network effects create moat
5. **Experienced Team**: Deep domain expertise across critical areas
6. **Social Impact**: Positive mission alignment with strong business case
7. **Multiple Revenue Streams**: Diversified beyond single product
8. **Exit Optionality**: Multiple potential acquirers and paths to liquidity

## Next Steps

For investors interested in learning more:

1. **Detailed Due Diligence**: Access to data room with financials, contracts, technical documentation
2. **Customer References**: Speak with current enterprise and research customers
3. **Technical Deep Dive**: Review of datasets, anonymization, and platform
4. **Team Meetings**: Meet key team members and advisors
5. **Term Sheet Discussion**: Investment structure and terms

## Contact

**Investment Inquiries**:  
Email: investors@hollowhouseinstitute.org  
[Additional contact information]

**General Information**:  
Website: hollowhouseinstitute.org  
Email: info@hollowhouseinstitute.org

---

## Appendices

### Appendix A: Detailed Financial Model
[Available separately under NDA]

### Appendix B: Technical Architecture
[Platform and dataset infrastructure overview]

### Appendix C: Customer Case Studies
[Success stories and testimonials]

### Appendix D: Market Research
[Detailed market analysis and TAM/SAM/SOM]

### Appendix E: Compliance Documentation
[Legal opinions, privacy assessments, regulatory filings]

---

**CONFIDENTIAL DRAFT**: This document is for investor review only and contains forward-looking statements. Actual results may differ materially from projections. This does not constitute an offer to sell securities.

**Version**: 1.0-DRAFT  
**Last Updated**: 2025-12-02  
**Next Update**: Following Series A completion or annual review
